Discuss innovative applications and recent technological developments within the fields of multiplexed assays and flow cytometry
The programme brings together world leaders from international pharmaceutical organisations and leading biotechnology companies to discuss the latest in multi-omic cytometry and its application in immuno-oncology and infectious diseases alongside advances in multiplexing tools for biomarker analysis.
Full details on the Symposium including the presentations, topic areas and confirmed speakers will be released in the conference brochure in the coming weeks
Registration for the Flow Cytometry & Multiplexing Tools Symposium is now open. Please click the button below to register for this event.
Our LinkedIn group aims to foster discussion and collaboration between experts interested in the latest biomarker strategies and technologies
Attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions working within multi-omic cytometry and its application in immuno-oncology and infectious diseases
Stream 1: Latest Strategies And Technologies Progressing Flow Cytometry
Stream Two: Multiplexing Tools & Technologies For Biomarker Analysis
The Symposium brings together a panel of prominent leaders, engineers and scientists sharing new case studies, innovative data and industry outlook for the future
Massachusetts General Hospital
Nottingham Trent University
Networking and knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual, remote experiences.
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer flexible solutions for hospitals, reference labs, and researchers, as well as innovative xMAP® and flow cytometry solutions that span a wide variety of applications, including molecular diagnostics, drug discovery, life science research, immunology, and personalized medicine. For further information, please visit luminexcorp.com.
Abcam is a global life science company enabling scientific breakthroughs by serving life scientists to achieve their mission, faster. We identify, develop, and provide high-quality biological reagents, protein tools and custom cell engineering to drive crucial research, drug discovery, diagnostic and therapeutic applications. Collaborating across the life science industry, our aim is that all life scientists will have access to the newest and best proteomic research tools and solutions. Our innovative products help accelerate the global understanding of biology and enable discoveries that positively impact society, including advances in human health, sustainable agriculture and environmental management.